Position paper of the Working Group of Three Polish National Consultants in: internal medicine, gastroenterology and cardiology concerning the rules of gastrointestinal complications’ prevention during the antiplatelet treatment Position paper
Article Sidebar
Published:
Sep 30, 2009
Main Article Content
Abstract
None
Article Details
How to Cite
Imiela , J., Opolski , G., Rydzewska , G., Baczewska-Mazurkiewicz, D., Małecki , R., & Filipiak , K. J. (2009). Position paper of the Working Group of Three Polish National Consultants in: internal medicine, gastroenterology and cardiology concerning the rules of gastrointestinal complications’ prevention during the antiplatelet treatment. Medycyna Faktow (J EBM), 2(3(4), 43-46. Retrieved from https://journalsmededu.pl/index.php/jebm/article/view/2646
Issue
Section
Articles
Copyright © by Medical Education. All rights reserved.
References
1. Bhatt D.L., Scheiman J., Abraham N.S. et al.: ACCF/ACG/AHA 2008 Expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. J. Am. Coll. Cardiol. 2008; 52:1502-1517.
2. Gilard M., Arnaud B., Cornily J.C. et al.: Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study. J. Am. Coll. Cardiol. 2008; 51:256-260.
3. Small D.S., Farid N.A., Payne C.D. et al.: Effects of the proton pump inhibitor lansoprazole on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel. J. Clin. Pharmacol. 2008; 48:475-84.
4. Ho P.M., Maddox T.M., Wang L. et al.: Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome. JAMA 2009; 301:937-944.
5. Siller-Matula J.M., Spiel A.O., Lang I.M. et al.: Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel. Am. Heart J. 2009; 157:148.e1-5.
6. Juurlink D.N., Gomes T., Ko D.T. et al.: A population-based study of the drug interaction between proton pump inhibitors and clopidogrel. CMAJ 2009; 31:180-187.
7. Sibbing D., Morath T., Stegherr J. et al.: Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel. Thromb. Haemostasis 2009; 101(4): 714-719.
2. Gilard M., Arnaud B., Cornily J.C. et al.: Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study. J. Am. Coll. Cardiol. 2008; 51:256-260.
3. Small D.S., Farid N.A., Payne C.D. et al.: Effects of the proton pump inhibitor lansoprazole on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel. J. Clin. Pharmacol. 2008; 48:475-84.
4. Ho P.M., Maddox T.M., Wang L. et al.: Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome. JAMA 2009; 301:937-944.
5. Siller-Matula J.M., Spiel A.O., Lang I.M. et al.: Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel. Am. Heart J. 2009; 157:148.e1-5.
6. Juurlink D.N., Gomes T., Ko D.T. et al.: A population-based study of the drug interaction between proton pump inhibitors and clopidogrel. CMAJ 2009; 31:180-187.
7. Sibbing D., Morath T., Stegherr J. et al.: Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel. Thromb. Haemostasis 2009; 101(4): 714-719.